These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21181914)

  • 41. Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil.
    Vitral CL; Ospina FL; Artimos S; Melgaço JG; Cruz OG; de Paula VS; Luz SB; Freire M; Gaspar LP; Amado LA; Engstrom EM; Fortes CD; Souza TC; Dias MN; Gaspar AM; Souto FJ
    Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):652-8. PubMed ID: 22850956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.
    Weinberg A; Gona P; Nachman SA; Defechereux P; Yogev R; Hughes W; Wara D; Spector SA; Read J; Elgie C; Cooper M; Dankner W;
    J Infect Dis; 2006 Jan; 193(2):302-11. PubMed ID: 16362896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of hepatitis A virus antibodies after bone marrow transplantation.
    Godoi ER; de Souza VA; Cakmak S; Machado AF; Vilas Boas LS; Machado CM
    Bone Marrow Transplant; 2006 Jul; 38(1):37-40. PubMed ID: 16715111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose.
    Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS
    Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial.
    Mayorga Pérez O; Herzog C; Zellmeyer M; Loáisiga A; Frösner G; Egger M
    J Infect Dis; 2003 Sep; 188(5):671-7. PubMed ID: 12934183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs.
    Pancharoen C; Mekmullica J; Thisyakorn U; Kasempimolporn S; Wilde H; Herzog C
    Clin Infect Dis; 2005 Nov; 41(10):1537-40. PubMed ID: 16231271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Routine testing for IgG antibodies against hepatitis A virus in Israel.
    Samuels N
    BMC Public Health; 2005 Jun; 5():60. PubMed ID: 15935104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination.
    Kyrka A; Tragiannidis A; Cassimos D; Pantelaki K; Tzoufi M; Mavrokosta M; Pedeli X; Athanassiadou F; Hatzimichael A; Konstantopoulos A; Kafetzis D; Papaevangelou V
    J Med Virol; 2009 Apr; 81(4):582-7. PubMed ID: 19235841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of markers of hepatotropic viruses A, B, C and the efficacy of vaccination against hepatitis A and hepatitis B among medical students.
    Jabłkowski M; Kuydowicz J; Strzelczyk J; Białkowska J
    Med Sci Monit; 2002 Nov; 8(11):CR762-6. PubMed ID: 12444381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Chronic hepatitis C and risk for hepatitis A infection].
    Chlabicz S; Grzeszczuk A
    Przegl Epidemiol; 2001; 55(3):281-6. PubMed ID: 11761835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis A seroprevalence in public school children in Campos dos Goytacazes, Rio de Janeiro State, Brazil, prior to the introduction of the hepatitis A universal childhood vaccination.
    Kury CM; Pinto MA; Silva JP; Cruz OG; Vitral CL
    Cad Saude Publica; 2016 Nov; 32(11):e00175614. PubMed ID: 27982290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A seroepidemiologic study of Helicobacter pylori and hepatitis A virus infection in primary school students in Taipei.
    Lin HY; Chuang CK; Lee HC; Chiu NC; Lin SP; Yeung CY
    J Microbiol Immunol Infect; 2005 Jun; 38(3):176-82. PubMed ID: 15986067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seropositivity among Korean Young Adults Approximately 2 Years after a Single-Dose Vaccination against Hepatitis A Virus.
    Song YJ; Lim J; Park WS; Sohn H; Lee MS; Shin DH; Kim CB; Kim H; Oh GJ; Ki M
    PLoS One; 2015; 10(11):e0142297. PubMed ID: 26540392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients.
    Arguedas MR; Johnson A; Eloubeidi MA; Fallon MB
    Hepatology; 2001 Jul; 34(1):28-31. PubMed ID: 11431730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response to hepatitis A vaccine in HIV-positive patients.
    Weissman S; Feucht C; Moore BA
    J Viral Hepat; 2006 Feb; 13(2):81-6. PubMed ID: 16436125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison of antibody persistence between live attenuated and inactivated hepatitis A vaccines].
    Liu HF; Zhang XJ; Zhang JL
    Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):300-3. PubMed ID: 20077725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.